Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001078782-13-001970
Filing Date
2013-10-04
Accepted
2013-10-04 17:37:26
Documents
1
Period of Report
2013-10-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1463
  Complete submission text file 0001078782-13-001970.txt   3033
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17901 CHENAL PARKWAY LITTLE ROCK AR 72223
Business Address
Kenny Peter C (Reporting) CIK: 0001574401 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35814 | Film No.: 131137576